EUVIMEDEUVIMED entdecken
Crossref

Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project

Mallory R Taylor iD, James R Anderson, Julie R Park, Meredith S Irwin iD, Mark A Applebaum iD, Navin R Pinto, Keri Streby iD, Sara M Federico, Carolina Rosswog, Miki Ohira iD, Pei-Chi Kao, Wendy B London iD und 1 weitere

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31968 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Mallory R Taylor und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Hematology/Oncology, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Neuroblastoma, N-Myc Proto-Oncogene Protein. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Toddlers (age 365–

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaN-Myc Proto-Oncogene ProteinHumansInfantMaleFemalePrognosisSurvival RateFollow-Up StudiesGene Amplification

Stichwörter der Autor:innen

international databaseneuroblastomaoutcomes

Substanzen

N-Myc Proto-Oncogene ProteinMYCN protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Hematology/Oncology, University of Washington, Seattle, Washington, USA.
  • Ben Towne Center For Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA.
  • College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Department of Pediatrics, University of Chicago, Chicago, Illinois, USA.

ORCID-Profile: Mallory R Taylor, Meredith S Irwin, Mark A Applebaum, Keri Streby, Miki Ohira, Wendy B London

Zitieren

APA

Taylor, M. R., Anderson, J. R., Park, J. R., Irwin, M. S., Applebaum, M. A., Pinto, N. R., Streby, K., Federico, S. M., Rosswog, C., Ohira, M., Kao, P. C., London, W. B., & Cash, T. (2025). Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31968

Vancouver

Taylor MR, Anderson JR, Park JR, Irwin MS, Applebaum MA, Pinto NR, et al. Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31968

BibTeX
@article{Taylor2025,
  author = {Taylor, Mallory R and Anderson, James R and Park, Julie R and Irwin, Meredith S and Applebaum, Mark A and Pinto, Navin R and Streby, Keri and Federico, Sara M and Rosswog, Carolina and Ohira, Miki and Kao, Pei-Chi and London, Wendy B and Cash, Thomas},
  title = {Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31968}
}
Kostenlos starten →